IOVANCE BIOTHERAPEUT

IOVA
Delayed Quote. Delayed  - 06/14 04:00:00 pm
23.87USD +1.79%

Turn to zoom
Prev.23.4500
Open23.3300
High24.3700
Low23.2200
Volume6 388 263
Latest news
6h ago
4d ago
4d ago
4d ago
Chart IOVANCE BIOTHERAPEUTICS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance27,027,031,4
Spread/Res.-11%-11%-24%
Spread/Supp.46%46%33%
Support16,316,317,9
Financials
Sales 2021 - - -
Net income 2021 -306 M - -
Net cash 2021 405 M - -
P/E ratio 2021 -11,6x
Yield 2021 -
Capitalization 3 584 M 3 584 M -
EV / Sales 2021 -
EV / Sales 2022 883x
Nbr of Employees 241
Free-Float 93,7%
Company
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells. The...

>> Read more
Sector :
Bio Diagnostics & Testing
Calendar :
2021-06-17 Presentation
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 14
Average target price 36,50 $
Last Close Price 23,87 $
Spread / Highest target 114%
Spread / Average Target 52,9%
Spread / Lowest Target -24,6%